Financhill
Back

Carlisle Companies Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
29

CSL
Carlisle Companies

Last Price:
$370.74
Seasonality Move:
5.86%
Sell
45

DRUG
Bright Minds Biosciences

Last Price:
$39.35
Seasonality Move:
-32.13%
Sell
29
Carlisle Companies (CSL) is a Sell

Is Carlisle Companies a Buy, Sell or Hold?

  • The current Carlisle Companies [CSL] share price is $371.13. The Score for CSL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • CSL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $39.85. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CSL Stock Price Chart

What is Carlisle Companies's stock price today?

  • The Carlisle Companies share price today is $371.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CSL is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $39.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

CSL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -18.91 Sell
Relative Strength Index (14 RSI): 25.56 Sell
Chaikin Money Flow: 123093 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (375.89 - 439.53) Sell
Bollinger Bands (100): (398.8 - 455.44) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 51.96 Buy
Chaikin Money Flow: 6916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.23 - 42.31) Buy
Bollinger Bands (100): (3.23 - 44.21) Buy

CSL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 372.27 Sell
20-day SMA: 397.13 Sell
50-day SMA: 424.62 Sell
200-day SMA: 415.52 Sell
8-day EMA: 374.53 Sell
20-day EMA: 392.9 Sell
50-day EMA: 414.68 Sell
200-day EMA: 403.44 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.78 Buy
20-day SMA: 38.81 Buy
50-day SMA: 41.79 Sell
200-day SMA: 12.42 Buy
8-day EMA: 39 Buy
20-day EMA: 39.09 Buy
50-day EMA: 36.04 Buy
200-day EMA: 18.43 Buy

Carlisle Companies Earnings Growth & CSL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.58 per share, and an increase next year of $2.47 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Carlisle Companies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):